Mode
Text Size
Log in / Sign up

Age, smoking, and diabetes are associated with increased risk of postmenopausal osteoporosisRisk factors for osteoporosis in postmenopausal women identified

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that age, smoking, and diabetes are associated with increased risk of postmenopausal osteoporosis.

This meta-analysis synthesizes data from 36 studies involving 32,366 participants to identify risk factors for postmenopausal osteoporosis (PMO). The analysis found an overall prevalence of osteoporosis of 33.87%. Several factors were associated with an increased risk of PMO, including age (1.16), postmenopausal duration (1.23), and specifically a postmenopausal duration of more than 10 years (2.81). Other risk factors included number of births (1.32), having 2 or more births (3.07), smoking (1.55), lack of exercise (1.66), history of previous fracture (1.86), and diabetes mellitus (2.24).

Conversely, certain factors were associated with a lower risk of PMO, including body mass index (0.80), older age at menopause (0.92), and estrogen replacement therapy (0.45). The authors noted significant limitations, including high statistical heterogeneity for several factors and a data source predominantly from Chinese cohorts.

Clinically, these findings provide a framework for risk stratification and targeted prevention in postmenopausal women. However, the results are based on observational studies using multivariate logistic regression and do not establish causation. Furthermore, the findings may not be generalizable outside of East Asian populations due to the specific distribution of the source data.

How this fits prior evidence

This meta-analysis addresses a gap in identifying specific clinical risk factors for postmenopausal osteoporosis. While previous evidence has explored the gut microbiota-NGF-bone axis as a conceptual framework and the role of coumarins in modulating inflammatory mediators, this study provides a broader overview of demographic and lifestyle risk factors, such as smoking and diabetes, and the protective association of estrogen replacement therapy.

Living with osteoporosis means dealing with bones that become brittle and break more easily. For postmenopausal women, identifying the right risk factors is the first step toward better prevention. A large review of 36 different studies involving over 32,000 women looked at what drives this condition.

The data shows that several lifestyle and health factors increase the risk of developing osteoporosis. These include smoking, a lack of regular exercise, and having a history of previous fractures. Health conditions like diabetes also show a significant link to higher risk. On the other hand, factors like a higher body mass index and estrogen replacement therapy were found to have a protective effect.

It is important to note that these findings are based on observational data, which means they show a link but do not prove that one thing causes another. Additionally, most of the data came from women in China, so the results might not apply to everyone. Talk to your doctor to see how these specific factors might affect your personal health plan.

What this means for you:
Factors like smoking, lack of exercise, and diabetes increase osteoporosis risk in postmenopausal women.

Common questions

What lifestyle habits increase osteoporosis risk?

Smoking and a lack of exercise are both linked to a higher risk of osteoporosis in postmenopausal women. The study found that these factors significantly increase the likelihood of developing the condition. You should talk to your doctor about how to incorporate safer, more consistent exercise into your daily routine.

How does diabetes affect bone health?

The data shows that having diabetes mellitus is linked to an increased risk of osteoporosis in postmenopausal women. Because this condition can impact bone density, it is important to work closely with your healthcare provider to manage your health and monitor your bone strength.

Are there any protective factors for bone health?

The study found that a higher body mass index (BMI) and estrogen replacement therapy were associated with a lower risk of osteoporosis. However, because the data mostly came from East Asian groups, you should consult your doctor to see if these factors apply to your specific situation.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedSep 2026
View Original Abstract ↓
ObjectiveThis meta-analysis aimed to investigate the prevalence and risk factors for Postmenopausal Osteoporosis (PMO) to provide a basis for early clinical identification of high-risk populations.MethodsWe systematically searched English databases (PubMed, Cochrane Library, Embase, Web of Science) and Chinese databases (CNKI, Wanfang Data, VIP Database, Sinomed) up to May 2026 for observational studies using multivariate logistic regression to analyze risk factors for PMO. The meta-analysis was conducted following the PRISMA guidelines. After data extraction, pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated using STATA 15.0.ResultsA total of 37 studies involving 32,366 postmenopausal women were included. Among these, 36 studies reported the prevalence of osteoporosis, yielding an overall prevalence of 33.87%. The meta-analysis identified the following factors as significantly associated with an increased risk of PMO: Age (OR = 1.16); Postmenopausal duration (OR = 1.23); Postmenopausal duration > 10 years (OR = 2.81); Number of births (OR = 1.32); With ≥ 2 births (OR = 3.07); Smoking (OR = 1.55); Lack of exercise (OR = 1.66); History of previous fracture (OR = 1.86); Diabetes mellitus (OR = 2.24); Conversely, a higher body mass index (BMI) (OR = 0.80), older age at menopause (OR = 0.92), and estrogen replacement therapy (OR = 0.45) were identified as protective factors. No significant association was found for the following factors: Family history of osteoporosis; Regular exercise; Hypertension; Calcium supplementation.ConclusionOsteoporosis is highly prevalent among postmenopausal women, particularly within the East Asian cohorts that comprised the majority of this meta-analysis. Several independent risk factors were identified, including age, longer postmenopausal duration, multiparity, smoking, physical inactivity, previous fracture, and diabetes. Estrogen replacement therapy showed a strong protective effect. While high statistical heterogeneity for several factors was addressed using random-effects models and sensitivity analyses, these findings—derived predominantly from Chinese cohorts—should be interpreted with consideration of this variability. Nevertheless, they provide a robust framework for early risk stratification and targeted prevention strategies in this high-risk population.Systematic review registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD420251274575.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.